Veitschegger, Andrea (ÖGMBT 201105 Managing Director) |
Managing Director |
Österreichische Gesellschaft für Molekulare Biowissenschaften und Biotechnologie (ÖGMBT) |
Austria |
Engel, Jürgen (Æterna Zentaris 200504) |
Chief Operating Officer (COO) |
Æterna Zentaris (Group) |
Canada |
Guenther, Eckhard (Aeterna Zentaris 201611 VP Alliance Management) |
Business Development Manager / Strategy Manager |
Æterna Zentaris (Group) |
Germany |
Kleemann, Axel (Asta Medica 1987–2000 before Degussa ua) |
Board member |
Æterna Zentaris (Group) |
Germany |
Teifel, Michael (Æterna Zentaris 201308 VP Preclinical Developm at Æterna Zentaris GmbH) |
Research & Development Manager |
Æterna Zentaris (Group) |
Germany |
Lippold, Marcus ([iito] Business Intelligence 2002–) |
Company Founder |
[iito] Business Intelligence |
Germany |
Debel, Karsten (Zytomed Systems 200912 Managing Director) |
Managing Director |
ZytoVision (Group) |
Germany |
Dittmer, Thomas (Zytomed Systems 200912 Managing Director) |
Managing Director |
ZytoVision (Group) |
Germany |
Hauke, Sven (ZytoVision GmbH 200405–200902– Managing Director + founder before Alcedo Biotech) |
Managing Director |
ZytoVision (Group) |
Germany |
Meiboom, Meike (ZytoVision 200705 Scientist) |
n. a. |
ZytoVision (Group) |
Germany |
Rogalla, Piere (ZytoVision GmbH 200405–200902– Managing Director + founder before Alcedo Biotech Managing Director) |
Managing Director |
ZytoVision (Group) |
Germany |
Weyrauch, Kerstin (Zytomed Systems 200912 Managing Director) |
Managing Director |
ZytoVision (Group) |
Germany |
Weilguni, Peter C. (Cytoprotec 201301 Managing Director) |
Managing Director |
Zytoprotec GmbH |
Austria |
Schier, Robert (Zürcher Kantonalbank 201909 Investment Director PE/V Health-Tech at Swisscanto Invest) |
Investment Manager |
Zürcher Kantonalbank (ZKB) |
Switzerland |
Schoch, Daniel (Zürcher Kantonalbank 201808 Head of Start-up FInance) |
Investment Manager |
Zürcher Kantonalbank (ZKB) |
Switzerland |
Redant, Emile (Zymofix 202411 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Zymofix N.V. |
Belgium |
Tehrani, Ali (Zymeworks 201510 CEO) |
Chief Executive Officer (CEO) |
Zymeworks (Group) |
Canada |
Odgaard, Katie (Zyme Communications 201108 Senior Account Manager before College Hill Life Sciences) |
Public Relations Manager / Investor Relations Manager |
Zyme Communications Ltd. |
United Kingdom (GB) |
Schulz, Wolfgang (Zweckverband Landeswasserversorgung in Langenau 201504) |
n. a. |
Zweckverband Landeswasserversorung (Baden-Württemberg / Bayern) |
Germany |
Jünger, Katharina (TeleClinic 2015– Managing Director + Co-Founder) |
Managing Director |
Zur Rose Group (Group) |
Germany |
Lüthi, Lisa (Zur Rose Group 202007 Head of Group Communications) |
Public Relations Manager / Investor Relations Manager |
Zur Rose Group (Group) |
Switzerland |
Müller, Maximilian (TeleClinic 2015– Managing Director) |
Managing Director |
Zur Rose Group (Group) |
Germany |
Oberhänsli, Walter (Zur Rose Group 202007 CEO) |
Chief Executive Officer (CEO) |
Zur Rose Group (Group) |
Switzerland |
Ziwica, Marcel (Zur Rose Group 202007 CFO) |
Chief Financial Officer (CFO) |
Zur Rose Group (Group) |
Switzerland |
Cansier, Alexander (PANATecs 201003 Head Quality Assurance) |
n. a. |
Zukunftsfonds Heilbronn (Group) |
Germany |
Finkbeiner, Petra (PANATecs 201003) |
Sales Manager / Marketing Manager |
Zukunftsfonds Heilbronn (Group) |
Germany |
Flad, Thomas (PANATecs 201104 Head Technical Sales before 200512 Managing Director) |
Sales Manager / Marketing Manager |
Zukunftsfonds Heilbronn (Group) |
Germany |
Merz, Benedikt (PANATecs –201105c Managing Director) |
Managing Director |
Zukunftsfonds Heilbronn (Group) |
Germany |
Schwarz, Gerold (Biotecon 201701– Product Manager before Analytik Jena + Bruker Datlonics + PANATecs) |
Product Manager (personnel) |
Zukunftsfonds Heilbronn (Group) |
Germany |
Steffen, Günter (ZFHN Zukunfsfonds Heilbronn + 4/10 existent Chair Advisory Board of PANATecs) |
Investment Manager |
Zukunftsfonds Heilbronn (Group) |
Germany |
Villinger, Thomas R. (Tom) (ZFHN Zukunftsfonds Heilbronn 201910 CEO) |
Chief Executive Officer (CEO) |
Zukunftsfonds Heilbronn (Group) |
Germany |
Willinger, Thomas R. (ZFHN Zukunftsfonds Heilbronn 201105 Managing Director) |
Managing Director |
Zukunftsfonds Heilbronn (Group) |
Germany |
Schnappauf, Georg (ZSP Patentanwälte 201704 Partner) |
Patent Attorney |
ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) |
Germany |
Zwicker, Jörk (ZSP Patentanwälte 201704 Partner beore Boehmert & Boehmert) |
Patent Attorney |
ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) |
Germany |
Polzer, Robert (Zoetis 202307 EVP + President RnD) |
Research & Development Manager |
Zoetis (Group) |
United States (USA) |
Cavdar, Avni (Zivak Technologies 201310 President) |
President/Director/Head Business Group/Unit/Division |
Zivak Technologies (TR) |
Turkey |
Cheng, Ziqiang (Zack) (Zion Pharma 202305 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Zion Pharma Ltd. (CN) |
China |
French, J. Michael (Zion Pharma 202305 SVP CorpDev before MDRNA + Marina Biotech + Sirna Tx + Entelos +Bayer) |
Business Development Manager / Strategy Manager |
Zion Pharma Ltd. (CN) |
China |
Zhou, Ding (Zion Pharma 202305 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Zion Pharma Ltd. (CN) |
China |
Rüger, Simon (ZIM Plant Technology GmbH 201204 Managing Director) |
Managing Director |
ZIM Plant Technology GmbH |
Germany |
de Lange, Lex (Zernike 201008) |
Chief Executive Officer (CEO) |
Zernike (Group) |
Netherlands |
Berg, Niclas (Zeria 202307 Lead Corporate Communications at Tillotts Pharma) |
Public Relations Manager / Investor Relations Manager |
Zeria (Group) |
Switzerland |
Spleiss, Johannes (Zeria 202307 Head Scientific Affairs Tillotts Pharma + 202307– CEO of Mage Biologics) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Zeria (Group) |
Switzerland |
Tóth von Kiskér, Thomas A. (Zeria 202005 CEO of Tillotts Pharma AG) |
Chief Executive Officer (CEO) |
Zeria (Group) |
Switzerland |
Schleper, Christa (ZEB 200110 Head) |
n. a. |
Zentrum für molekulare Evolution und Biodiversität (ZEB) |
Germany |
Klaue, Daniel (Zellmechanik Dresden 202011 Managing Director) |
Managing Director |
Zellmechanik Dresden GmbH |
Germany |
Schulte, Gerrit (Zeiss 202303 Head of Zeiss Ventures) |
Investment Manager |
Zeiss Ventures |
Germany |
Hils, Martin (Zedira 201106 CEO + co-founder before N-Zyme Biotec) |
Managing Director |
Zedira GmbH |
Germany |
Pasternack, Ralf (Zedira 201106 Managing Director + co-founder before N-Zyme Biotec 200506 Managing Director) |
Managing Director |
Zedira GmbH |
Germany |
Calzolari, Simone (ZeClinics 202102 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
ZeClinics (ES) |
Spain (España) |
Dulac, Emmanuel (Zealand Pharma 201909–202203 CEO LEFT 3/22) |
Chief Executive Officer (CEO) |
Zealand Pharma (Group) |
Denmark |
Hofmann, Martin (ZAR 202404 Managing Director + CDO of ZAR Real Estate Holding) |
Managing Director |
ZAR (Group) |
Germany |
Weber, Christian (ZAR 202404 Managing Director + Co-Founder of ZARWEB GmbH) |
Managing Director |
ZAR (Group) |
Germany |
Zarges, Marco (ZAR Group 202405 Owner) |
n. a. |
ZAR (Group) |
Germany |
Castorina, Maurizio (Zambon 201511 CEO) |
Chief Executive Officer (CEO) |
Zambon (Group) |
Italy |
Henig, Noreen Roth (201807– CMO before ProQR Therapeutics + Gilead Sciences) |
Chief Medical Officer (CMO) |
Zambon (Group) |
Germany |
Keywood, Charlotte (Zambon 201603 Head RnD before Addex Pharma CMO) |
Research & Development Manager |
Zambon (Group) |
Italy |
Shadday, Peter (Breath Therapeutics 201810– CCO before Vertex + Lundbeck + Gilead + Novartis) |
Chief Commercial Officer (CCO) |
Zambon (Group) |
Netherlands |
Stegemann, Jens (Breath Therapeutics 201609– CEO) |
Managing Director |
Zambon (Group) |
Germany |
Tascione, Roberto (Zambon 201907 CEO) |
Chief Executive Officer (CEO) |
Zambon (Group) |
Italy |
Zambon, Elena (Zambon 201907 President) |
Board member |
Zambon (Group) |
Italy |
Artusio, Lionel (Z Impact Ventures 202407 General Partner) |
General Partner (venture partner) |
Z Impact Ventures (d/b/a Zebra Impact Ventures) |
Switzerland |
Tellier, Baptiste (Fall Line Capital 202407 Managing Director) |
Managing Director |
Z Impact Ventures (d/b/a Zebra Impact Ventures) |
Switzerland |
Ehm, Alexander (Yumab 202109 Head of Global Business Development) |
Business Development Manager / Strategy Manager |
Yumab GmbH |
Germany |
Kirchner, Linda (Yumab 2002205 Head of Business + Finance + Corat Therapeutics 202207) |
Business Development Manager / Strategy Manager |
Yumab GmbH |
Germany |
Schirrmann, Thomas (Yumab GmbH 201907 Managing Director + Covat Therapeutics 202005– Managing Director) |
Managing Director |
Yumab GmbH |
Germany |
Passmore, David (Yumab 202005 Business Development) |
Business Development Manager / Strategy Manager |
Yumab (Group) |
United States (USA) |
Lee, Jung Hee (Yuhan 201907 CEO of Yuhan Corp) |
Chief Executive Officer (CEO) |
Yuhan Corporation (Yu Han) (000100:KS) |
Korea, Republic of |
Jean-Mairet, Joël (Ysios Capital 201206) |
n. a. |
Ysios Capital (Group) |
Spain (España) |
Deigin, Yuri (Youth Bio 202209 CEO) |
Chief Executive Officer (CEO) |
Youth Bio |
|
Little, Stephen (Premaitha Health 201512 CEO before Qiagen + DxS) |
Chief Executive Officer (CEO) |
Yourgene Health (Group) |
United Kingdom (GB) |
Gilani, Saad (Yorkville Group 201308 Head of Healthcare Group at Yorkville Advisors) |
Investment Manager |
Yorkville Group (Group) |
United States (USA) |
Nowak, Michael J. (Yorkville 201108 Managing Director of Yorkville Advisors LLC) |
Managing Director |
Yorkville Group (Group) |
United States (USA) |
Lehmann, Heike (Insilico Biotechnology 201206 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Yokogawa (Group) |
Germany |
Mauch, Klaus (Insilico Biotechnology 2004 became CEO before founder) |
Chief Executive Officer (CEO) |
Yokogawa (Group) |
Germany |
Nakao, Hiroshi (Yokogawa 202111 VP + Head of Life Business) |
President/Director/Head Business Group/Unit/Division |
Yokogawa (Group) |
Japan |
Nara, Hitoshi (Yokogawa 202111 CEO) |
Chief Executive Officer (CEO) |
Yokogawa (Group) |
Japan |
Stahnke, Bettina (Insilico Biotechnology 201402 Business Development Manager) |
Business Development Manager / Strategy Manager |
Yokogawa (Group) |
Germany |
Germa, Christian P. (Ymmunobio 202311 CFO) |
Chief Financial Officer (CFO) |
Ymmunobio AG |
Switzerland |
Rupalla, Katrin (Ymmunobio 202206 CEO) |
Chief Executive Officer (CEO) |
Ymmunobio AG |
Switzerland |
Schiemann, Peter (Ymmunobio 2021– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Ymmunobio AG |
Switzerland |
Fischl, Wolfgang (Ygion Biomedical 202405 CEO + CSO + Co-Founder) |
Chief Executive Officer (CEO) |
Ygion Biomedical GmbH |
Austria |
Zettl, Sophie (Ygion Biomedical 202405 CBO formerly CEBINA 202003 before Arsanis + MedImmune/AZ) |
Business Development Manager / Strategy Manager |
Ygion Biomedical GmbH |
Austria |
Sarif, Zina (Yendou 202205– Managing Director + Founder) |
Managing Director |
Yendou UG (haftungsbeschränkt) |
Germany |
Dyck, Joachim (Yaya Diagnostics 201311– Managing Director before AnagnosTec + Chimera Biotec) |
Managing Director |
Yaya Diagnostics GmbH |
Germany |
Radwan, Ashraf (Yas Holding 202211 CEO of GlobalOne Healthcare Holding) |
Chief Executive Officer (CEO) |
Yas Holding (Group) |
United Arab Emirates (UAE) |
Holsether, Svein Tore (Yara 201509– CEO) |
Chief Executive Officer (CEO) |
Yara (Group) |
Norway |
Stormorken, Pål O. (Yara 201702 Head of Application + Crop Management Systems) |
President/Director/Head Business Group/Unit/Division |
Yara (Group) |
Norway |
Sohler, Matthias (Yabeo Capital GmbH 202002 Managing Director + Founder) |
Managing Director |
Yabeo Capital GmbH |
Germany |
McIntire, Chris (ITT Corp 201009 President ITT Analytics) |
President/Director/Head Business Group/Unit/Division |
Xylem (Group) |
United States (USA) |
Marini, Luca (Xyence Capital 202205 CEO) |
Chief Executive Officer (CEO) |
Xyence Capital SGR |
Italy |
Petrovics, Tamás (Xund Solutions 202209 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Xund Solutions GmbH |
Austria |
Schmid, Tina (Xund Solutions 202209 Head of Communications) |
Public Relations Manager / Investor Relations Manager |
Xund Solutions GmbH |
Austria |
Eckhardt, Annette (Xtal Concepts 201208 Managing Director) |
Managing Director |
Xtal Concepts GmbH |
Germany |
Hilterhaus, Dierk (Xtal Concepts 201208 Managing Director) |
Managing Director |
Xtal Concepts GmbH |
Germany |
Jehle, Heinrich (3a-diagnostics 201910– Managing Director) |
Managing Director |
XPhyto Therapeutics (Group) |
Germany |
Seidel, Uwe (XotonicsMED GmbH 201607 Managing Director) |
Managing Director |
XotonicsMED GmbH |
Germany |
Anderson, Mary L. (Xoma 200803– VP Business Developm before Merck-Serono) |
Business Development Manager / Strategy Manager |
Xoma (Group) |
United States (USA) |
Bruchmann, Friderike (XO Life 202202 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
XO Life GmbH |
Germany |
Liwing, Johan (XNK Therapeutics 202203 CEO before JnJ + Roche) |
Chief Executive Officer (CEO) |
XNK Therapeutics AB |
Sweden |